Search Results

On-market purchases under the plan were made twice yearly, following the announcement of CSL's half and full year results Additional shares may be purchased by NEDs on-market at prevailing share prices in accordance with CSL's Securities Dealing Policy Post-Employment Benefits Superannuation contributions are made in accordance with legislation and are included in the reported base fee, and are not additional to the base fee.

On 17 August 2016, CSL announced its full year results for Esterase Inhibitor Subcutaneous (Human)) had been (b) of this Directors' Report.

Shares are purchased by NEDs on-market consideration of eight Global Biopharmaceutical companies of at prevailing share prices, twice yearly, after the announcement of CSL's half and full year results.

46 Unvested Rights represent Tranche 2 of the 2023 grant that will vest on 21 August 2023, following the release of full year financial results.

Rights are allocated in two tranches and vesting occurs following the disclosure of half year and full year financial results following the grant of Rights.

We look forward to sharing the full results of our phase 3 study in the coming months."

Travere Therapeutics intends to complete a full evaluation of the data from the DUPLEX Study and work with study investigators on future presentations and publication of the results at an upcoming medical meeting and/or in a peer-reviewed publication.

Release of Full Year From end of relevant financial year until the start of the trading day following the release Results to ASX

Eyo, who received an Uplifting Athletes grant to research SLC6A1, gives an update on his work and gives credit to the mom of a 5-year-old boy who personally recruited him..

CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.